Document is current
Any future updates will be listed below
-
Authors
Kleckner, Ian R. https://orcid.org/0000-0002-9828-9986
Manuweera, Thushini
Lin, Po-Ju
Chung, Kaitlin H.
Kleckner, Amber S.
Gewandter, Jennifer S.
Culakova, Eva
Tivarus, Madalina E.
Dunne, Richard F.
Loh, Kah Poh
Mohile, Nimish A.
Kesler, Shelli R.
Mustian, Karen M.
-
Funding
Funding for this research was provided by:
National Institutes of Health (K07CA221931)
National Institutes of Health,United States (R25CA102618, UG1CA189961, UG1CA189961, UG1CA189961)
- License Information
-
More Information
Article History
Received: 6 March 2024
Accepted: 2 September 2024
First Online: 21 September 2024
Declarations
:
: The questionnaire and methodology for this study were approved by the Human Research Ethics committee of the University of Rochester Medical Center (RSRB 66046).
: Informed consent was obtained from all individual participants included in the study.
: Although we do not believe there are any conflicts of interest, in full disclosure, here are the funding sources for this work and any *potential* conflicts of interest: This work was supported by the NCI (UG1CA189961 to KMM and Gary Morrow, R25CA102618 to Gary Morrow, and K07CA221931 to IRK). Resistance bands were generously donated by TheraBand. The authors also acknowledge training that contributed to this manuscript from the TREC Training Workshop (R25CA203650; PI: Melinda Irwin) and support with study logistics and accruals from the Clinical and Translational Science Institute grant support (UL1 TR002001 from the National Institutes of Health [NIH]). This publication was supported by funds from the Maryland Department of Health’s Cigarette Restitution Fund, no. CH-649-CRF (to support AK and IRK). In the last 36 months, JSG received grant funding from the NIH and consulting income from Algo Therapeutix, Eikonizo, and GW Pharma; she also owns vesting shares in Eisana Corp.
